CN104758909A - Traditional Chinese medicine composition for treating coronary heart disease - Google Patents
Traditional Chinese medicine composition for treating coronary heart disease Download PDFInfo
- Publication number
- CN104758909A CN104758909A CN201510200191.0A CN201510200191A CN104758909A CN 104758909 A CN104758909 A CN 104758909A CN 201510200191 A CN201510200191 A CN 201510200191A CN 104758909 A CN104758909 A CN 104758909A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- medicine composition
- radix
- rhizoma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The invention discloses a traditional Chinese medicine composition for treating coronary heart disease. The traditional Chinese medicine composition is prepared from the following traditional Chinese medicinal raw materials in parts by weight: 10-30 parts of codonopsis pilosula, 10-30 parts of roasted rhizoma atractylodis macrocephalae, 20-40 parts of herba lycopi, 20-40 parts of leonurus, 10-30 parts of radix cyathulae, 10-20 parts of peach kernels, 5-15 parts of flos carthami, 10-20 parts of trigone, 10-20 parts of curcuma zedoary, 10-30 parts of ligusticum wallichii, 10-30 parts of angelica sinensis, 10-30 parts of seeds of cowherb, 10-20 parts of pericarpium citri reticulatae viride, 10-20 parts of pericarpium citri reticulatae, 10-20 parts of radix aconiti lateralis preparata, 20-40 parts of astragalus membranaceus, 5-15 parts of Chinese dates and 5-15 parts of rhizoma zingiberis. The traditional Chinese medicine composition disclosed by the invention has the functions of soothing the liver, relieving depression, nourishing spleen, tonifying qi, tonifying kidneys, restoring yang, activating blood and removing stasis and is remarkable in curative effect and reliable in action when used for treating coronary heart disease; the component sources are wide; the traditional Chinese medicine composition is simple and convenient to prepare and free of toxic and side effects.
Description
Technical field
The present invention relates to a kind of medicinal preparation not determining structure of traditional herbal medicines, especially a kind of Chinese medicine composition for the treatment of coronary heart disease.
Background technology
Coronary heart disease is coronary atherosclerotic heart disease, also known as ischemic heart desease, is frequently-occurring disease common clinically, commonly encountered diseases.Its clinical manifestation has angina pectoris, myocardial infarction, arrhythmia, heart failure etc.Modern medicine is thought, coronary heart disease is due to coronary atherosclerosis, or thrombosis is attached on coronary blood tube wall and causes coronary stricture, reduced by coronary artery blood flow, when cardiac load increases suddenly, need blood volume to increase, exceed the compensatory capacity of coronary artery blood supply, or need blood volume not increase, but coronary spasm, decrease blood flow or above-mentioned factor exists simultaneously, all can cause heart sharply, ischemia, anoxia and angina pectoris occurs.At present, the main treatment means one of doctor trained in Western medicine is the formation preventing thrombosis with medicine, and it exists the undesirable deficiency of curative effect instability, course of disease length, recurrent exerbation, effect; Two is carry out coronary artery to expand art, but price costly, and has certain risk, most of patients can not be accepted, and be subject to the restriction of age and armarium again, can not extensively popularize.
The traditional Chinese medical science is thought, coronary heart disease main manifestations is deficiency in origin and excess in superficiality, simulataneous insufficiency and excessive, and its deficiency in origin can have yang blood and qi virtual loss, real is that the stagnation of QI, cold coagulation, expectorant are turbid, blood stasis, and again can be mutually sick each other, its pathogenesis is blockage of the cardiac vessels, and its sick position with the heart is and relevant with the dirty functional disorder of liver,spleen,kidney three.Controlling should invigorating the spleen and replenishing QI, soothing liver-QI for relieving depression, the kidney invigorating recuperating depleted YANG, blood circulation promoting and blood stasis dispelling.
According to theory of Chinese medical science, for the pathogeny of coronary heart disease, carry out dialectical composition of prescription, to reach the object for the treatment of both the principal and secondary aspects of a disease.
Summary of the invention
In order to overcome in prior art adopt chemoprophylaxis coronary heart disease to exist curative effect is undesirable, the course for the treatment of long to do and coronary artery somewhat expensive, deficiency that risk is large are expanded in operation, the invention provides a kind ofly to prepare conveniently, medicine source is wide, cost is low, evident in efficacy, reliable effect, the Chinese medicine composition for the treatment of coronary heart disease that has no side effect.
The technical solution adopted for the present invention to solve the technical problems is: a kind of Chinese medicine composition for the treatment of coronary heart disease, it is characterized in that: its raw material of Chinese medicine and weight are: Radix Codonopsis 10-30 part, Rhizoma Atractylodis Macrocephalae (parched) 10-30 part, Herba Lycopi 20-40 part, Herba Leonuri 20-40 part, Radix Cyathulae 10-30 part, Semen Persicae 10-20 part, Flos Carthami 5-15 part, Rhizoma Sparganii 10-20 part, Rhizoma Curcumae 10-20 part, Rhizoma Chuanxiong 10-30 part, Radix Angelicae Sinensis 10-30 part, Semen Vaccariae 10-30 part, Pericarpium Citri Reticulatae Viride 10-20 part, Pericarpium Citri Reticulatae 10-20 part, Radix Aconiti Lateralis Preparata 10-20 part, Radix Astragali 20-40 part, Fructus Jujubae 5-15 part, Rhizoma Zingiberis 5-15 part.
The preferred technical solution of the present invention is: a kind of Chinese medicine composition for the treatment of coronary heart disease, is characterized in that: its raw material of Chinese medicine and weight are: Radix Codonopsis 20 parts, Rhizoma Atractylodis Macrocephalae (parched) 20 parts, Herba Lycopi 30 parts, Herba Leonuri 30 parts, Radix Cyathulae 20 parts, 15 parts, Semen Persicae, 10 parts, Flos Carthami, Rhizoma Sparganii 15 parts, Rhizoma Curcumae 15 parts, Rhizoma Chuanxiong 20 parts, Radix Angelicae Sinensis 20 parts, Semen Vaccariae 20 parts, 15 parts, Pericarpium Citri Reticulatae Viride, Pericarpium Citri Reticulatae 15 parts, Radix Aconiti Lateralis Preparata 15 parts, the Radix Astragali 30 parts, 10 parts, Fructus Jujubae, Rhizoma Zingiberis 10 parts.
Chinese medicine composition of the present invention is under Traditional Chinese medical theory and clinical experience instruct, selected medicament composing prescription.In Chinese medicine composition of the present invention: Radix Codonopsis has effect of invigorating the spleen and replenishing QI, spleen invigorating lung benefiting; Rhizoma Atractylodis Macrocephalae (parched) has effect of dampness row water, QI invigorating, strengthening the spleen and stomach; Herba Lycopi has effect of blood circulation promoting and blood stasis dispelling, line water detumescence; Herba Leonuri has effect of promoting blood flow to regulate menstruation, blood stasis dispelling diuretic, heat-clearing and toxic substances removing; Radix Cyathulae has effect of eliminating blood stasis and inducing menstruation, easing joint movement, inducing diuresis for treating stranguria syndrome; Semen Persicae has effect of blood circulation promoting and blood stasis dispelling, loosening bowel to relieve constipation; Flos Carthami has effect of promoting blood circulation to restore menstrual flow, eliminating stasis to stop pain; Rhizoma Sparganii has effect of removing blood stasis circulation of qi promoting, removing food stagnancy pain relieving; Rhizoma Curcumae has effect of circulation of qi promoting removing blood stasis, removing food stagnancy pain relieving; Rhizoma Chuanxiong has effect of blood circulation promoting and blood stasis dispelling, activating QI to alleviate the depression, wind-expelling pain-stopping; Radix Angelicae Sinensis have enrich blood invigorate blood circulation, effect of menstruction regulating and pain relieving, loosening bowel to relieve constipation; Semen Vaccariae has promoting blood circulation to restore menstrual flow, reducing swelling and alleviating pain, expedites the emergence of effect of stimulating milk secretion; Pericarpium Citri Reticulatae Viride has the stagnant effect of soothing the liver dispelling the stagnated QI, removing food stagnancyization; Pericarpium Citri Reticulatae has effect of diuretic, drying dampness to eliminate phlegm in regulating qi-flowing for strengthening spleen, tune; Radix Aconiti Lateralis Preparata has recuperating depleted YANG and rescuing the patient from collapse, mend fire supporing yang, by effect of wind-cold damp pathogen; The Radix Astragali has effect that benefiting QI for strengthening the superficies, tonifying the lung spleen invigorating, arresting sweating are admittedly de-, wind dispelling fortune is malicious; Fructus Jujubae has effect of invigorating the spleen and replenishing QI, nourishing blood to tranquillize the mind; Rhizoma Zingiberis has warming spleen and stomach for dispelling cold, recuperating depleted YANG is promoted blood circulation, effect of warming the lung to resolve fluid-retention.Drug component in the present composition, through dialectical compatibility, complements each other using, has synergism, play effect of soothing liver-QI for relieving depression, invigorating the spleen and replenishing QI, the kidney invigorating recuperating depleted YANG, blood circulation promoting and blood stasis dispelling altogether, coronary heart disease is reached to the object for the treatment of both the principal and secondary aspects of a disease.
The component of the present composition all adopts natural raw material of Chinese medicine, and its preparation is easy, medicine source is wide, cost is low.It follows the prescriptions principle of the traditional Chinese medical science, and various component drug adopts the use that is decocted in water for oral dose.Through clinical practice checking, it is evident in efficacy, reliable effect, mild in medicine property and, do not occur toxic and side effects, total effective rate 88%, cure rate reaches 74%.
Detailed description of the invention
Below in conjunction with embodiment, the present invention will be further described.
Embodiment 1
Treat a Chinese medicine composition for coronary heart disease, its raw material of Chinese medicine and weight proportion are: Radix Codonopsis 20g, Rhizoma Atractylodis Macrocephalae (parched) 20g, Herba Lycopi 30g, Herba Leonuri 30g, Radix Cyathulae 20g, Semen Persicae 15g, Flos Carthami 10g, Rhizoma Sparganii 15g, Rhizoma Curcumae 15g, Rhizoma Chuanxiong 20g, Radix Angelicae Sinensis 20g, Semen Vaccariae 20g, Pericarpium Citri Reticulatae Viride 15g, Pericarpium Citri Reticulatae 15g, Radix Aconiti Lateralis Preparata 15g, Radix Astragali 30g, Fructus Jujubae 10g, Rhizoma Zingiberis 10g.
Embodiment 2
Treat a Chinese medicine composition for coronary heart disease, its raw material of Chinese medicine and weight proportion are: Radix Codonopsis 10g, Rhizoma Atractylodis Macrocephalae (parched) 30g, Herba Lycopi 20g, Herba Leonuri 40g, Radix Cyathulae 10g, Semen Persicae 20g, Flos Carthami 5g, Rhizoma Sparganii 20g, Rhizoma Curcumae 10g, Rhizoma Chuanxiong 30g, Radix Angelicae Sinensis 10g, Semen Vaccariae 30g, Pericarpium Citri Reticulatae Viride 10g, Pericarpium Citri Reticulatae 20g, Radix Aconiti Lateralis Preparata 10g, Radix Astragali 40g, Fructus Jujubae 5g, Rhizoma Zingiberis 15g.
Embodiment 3
Treat a Chinese medicine composition for coronary heart disease, its raw material of Chinese medicine and weight proportion are: Radix Codonopsis 30g, Rhizoma Atractylodis Macrocephalae (parched) 10g, Herba Lycopi 40g, Herba Leonuri 20g, Radix Cyathulae 30g, Semen Persicae 10g, Flos Carthami 15g, Rhizoma Sparganii 10g, Rhizoma Curcumae 20g, Rhizoma Chuanxiong 10g, Radix Angelicae Sinensis 30g, Semen Vaccariae 10g, Pericarpium Citri Reticulatae Viride 20g, Pericarpium Citri Reticulatae 10g, Radix Aconiti Lateralis Preparata 20g, Radix Astragali 20g, Fructus Jujubae 15g, Rhizoma Zingiberis 5g.
Embodiment 4
Treat a Chinese medicine composition for coronary heart disease, its raw material of Chinese medicine and weight proportion are: Radix Codonopsis 15g, Rhizoma Atractylodis Macrocephalae (parched) 25g, Herba Lycopi 25g, Herba Leonuri 35g, Radix Cyathulae 15g, Semen Persicae 18g, Flos Carthami 8g, Rhizoma Sparganii 18g, Rhizoma Curcumae 12g, Rhizoma Chuanxiong 25g, Radix Angelicae Sinensis 15g, Semen Vaccariae 25g, Pericarpium Citri Reticulatae Viride 12g, Pericarpium Citri Reticulatae 18g, Radix Aconiti Lateralis Preparata 12g, Radix Astragali 35g, Fructus Jujubae 8g, Rhizoma Zingiberis 13g.
Embodiment 5
Treat a Chinese medicine composition for coronary heart disease, its raw material of Chinese medicine and weight proportion are: Radix Codonopsis 25g, Rhizoma Atractylodis Macrocephalae (parched) 15g, Herba Lycopi 35g, Herba Leonuri 25g, Radix Cyathulae 25g, Semen Persicae 12g, Flos Carthami 13g, Rhizoma Sparganii 12g, Rhizoma Curcumae 18g, Rhizoma Chuanxiong 15g, Radix Angelicae Sinensis 25g, Semen Vaccariae 15g, Pericarpium Citri Reticulatae Viride 18g, Pericarpium Citri Reticulatae 12g, Radix Aconiti Lateralis Preparata 18g, Radix Astragali 25g, Fructus Jujubae 13g, Rhizoma Zingiberis 8g.
Chinese medicine composition in embodiment of the present invention decocting method routinely produces medicament.Concrete grammar is as follows: the raw material of Chinese medicine of prescription is put into container, adds cold water and covers powder, soaks 15 ~ 20 minutes, then adds water and do not have powder about 6 centimetres, carries out first time to decoct, and adopts intense fire to decoct, with slow fire boiling 20 ~ 30 minutes after boiling at a simmer; Second time decocts, and adds water and does not have powder about 6 centimetres, decocts 15 ~ 20 minutes after water boils.Twice decoction is removed slag extracting juice, merges.
The present invention, with a kind of Chinese medicine composition for the treatment of coronary heart disease given by embodiment 1, does clinical efficacy and is summarized as follows:
One, general data: Chinese medicine composition of the present invention is applied to clinical observation case 50 example, wherein man 20 example, female 30 example, 50 ~ 82 years old age.The shortest person of the course of disease 1 year, most elder reaches 10 years, average 1.5 years.
Two, diagnostic criteria:
1, feel oppressed pain in Danzhong or pareordia, very then the position such as inside the thorough left shoulder back of the body of pain, throat, left upper arm.In ictal or lasting puzzled.Normal with shortness of breath and palpitation, spontaneous perspiration, very then failing to sleep due to dyspnea;
2, feeling of oppression and pain in the chest is alleviated to dozens of minutes for general several seconds.Severe patient can sharp ache, continues not understand, cold extremities due to sweating, pale complexion, cyanosis of the lips and nails, palpitating speed, or the crisis such as arrhythmia, can die suddenly;
3, be more common in above middle age, often because overworking, depressed angry or polydipsia gluttony, impression is cold and bring out;
4, electrocardiogram, ambulatory electrocardiogram, exercise test etc. are looked into clarify a diagnosis.Make Myocardiase Examination if desired, Dynamic Observation of Electrocardiograms.
Three, usage and dosage: during clinical practice, one day potion, decocting twice extracting juice is about 300ml, and point early, late twice half an hour ante cibum warmly take.It within five days, is a course for the treatment of.
Four, criterion of therapeutical effect:
(1) cure: transference cure, electrocardiogram and regarding assay room check recovers normal;
(2) effective: symptom alleviates, attack times reduces, and the intermission extends, and lab testing is improved;
(3) invalid: cardinal symptom and electrocardiogram are without change.
Five, therapeutic effect: in this clinical observation case, takes medicine 3-15 the course for the treatment of, cures 37 examples, effective 7 examples, invalid 6 examples.There is not toxic and side effects in treatments period.
Six, model case:
Case 1: Xiao, man, 52 years old.Suffer from more than 2 years of History of Coronary Heart Disease, in the recent period because dizziness is heavy, cardiopalmus, lose heart, uncomfortable in chest, readme: speak and too urgently just cannot to breathe; Electrocardioscopy, is diagnosed as coronary heart disease.Take 3 courses for the treatment of of medicament prepared by Chinese medicine composition of the present invention, symptom greatly takes a turn for the better; Continue to take 4 courses for the treatment of, symptom disappears completely, recovery from illness; Follow up a case by regular visits to 1 year condition of illness not recur.
Case 2: Tang, female, 68 years old.Suffer from coronary heart disease, feeling oppressed pain recurrent exerbation more than 3 years in pareordia, takes western medicine, can obvious quick symptom relief, but always recur, and recent sensory symptoms increases the weight of.Take 4 courses for the treatment of of medicament prepared by Chinese medicine composition of the present invention, pain, symptom uncomfortable in chest are eased; Continue to take 5 courses for the treatment of, symptom disappears completely, recovery from illness.
Claims (2)
1. treat a Chinese medicine composition for coronary heart disease, it is characterized in that: its raw material of Chinese medicine and weight are: Radix Codonopsis 10-30 part, Rhizoma Atractylodis Macrocephalae (parched) 10-30 part, Herba Lycopi 20-40 part, Herba Leonuri 20-40 part, Radix Cyathulae 10-30 part, Semen Persicae 10-20 part, Flos Carthami 5-15 part, Rhizoma Sparganii 10-20 part, Rhizoma Curcumae 10-20 part, Rhizoma Chuanxiong 10-30 part, Radix Angelicae Sinensis 10-30 part, Semen Vaccariae 10-30 part, Pericarpium Citri Reticulatae Viride 10-20 part, Pericarpium Citri Reticulatae 10-20 part, Radix Aconiti Lateralis Preparata 10-20 part, Radix Astragali 20-40 part, Fructus Jujubae 5-15 part, Rhizoma Zingiberis 5-15 part.
2. a kind of Chinese medicine composition for the treatment of coronary heart disease according to claim 1, is characterized in that: its raw material of Chinese medicine and weight are: Radix Codonopsis 20 parts, Rhizoma Atractylodis Macrocephalae (parched) 20 parts, Herba Lycopi 30 parts, Herba Leonuri 30 parts, Radix Cyathulae 20 parts, 15 parts, Semen Persicae, 10 parts, Flos Carthami, Rhizoma Sparganii 15 parts, Rhizoma Curcumae 15 parts, Rhizoma Chuanxiong 20 parts, Radix Angelicae Sinensis 20 parts, Semen Vaccariae 20 parts, 15 parts, Pericarpium Citri Reticulatae Viride, Pericarpium Citri Reticulatae 15 parts, Radix Aconiti Lateralis Preparata 15 parts, the Radix Astragali 30 parts, 10 parts, Fructus Jujubae, Rhizoma Zingiberis 10 parts.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510200191.0A CN104758909A (en) | 2015-04-26 | 2015-04-26 | Traditional Chinese medicine composition for treating coronary heart disease |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510200191.0A CN104758909A (en) | 2015-04-26 | 2015-04-26 | Traditional Chinese medicine composition for treating coronary heart disease |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104758909A true CN104758909A (en) | 2015-07-08 |
Family
ID=53641225
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510200191.0A Pending CN104758909A (en) | 2015-04-26 | 2015-04-26 | Traditional Chinese medicine composition for treating coronary heart disease |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104758909A (en) |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2010134100A2 (en) * | 2009-05-22 | 2010-11-25 | Bio-Ved Pharmaceuticals, Pvt. Ltd. | A method for extraction of fractions containing pharmacologically active ingredients with less cytotoxicity from one or more plants |
| CN103316226A (en) * | 2013-06-24 | 2013-09-25 | 柳晖 | Traditional Chinese medicine composition for treating coronary heart disease |
-
2015
- 2015-04-26 CN CN201510200191.0A patent/CN104758909A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2010134100A2 (en) * | 2009-05-22 | 2010-11-25 | Bio-Ved Pharmaceuticals, Pvt. Ltd. | A method for extraction of fractions containing pharmacologically active ingredients with less cytotoxicity from one or more plants |
| CN103316226A (en) * | 2013-06-24 | 2013-09-25 | 柳晖 | Traditional Chinese medicine composition for treating coronary heart disease |
Non-Patent Citations (1)
| Title |
|---|
| 冯玲等: "稳心颗粒剂治疗冠心病心绞痛34例临床观察", 《中华中医药杂志》 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103272177A (en) | Traditional Chinese medicine composition for treating bone fracture | |
| CN103316204B (en) | One treats hypertensive Chinese medicine composition | |
| CN105079757A (en) | Traditional Chinese medicine composition for treating emphysema | |
| CN103316141B (en) | Traditional Chinese medicine composition for treating cervical spondylosis | |
| CN104940810A (en) | Traditional Chinese medicine composition for treating angina | |
| CN104013910A (en) | Traditional Chinese medicine composition for treating hypertension | |
| CN105079551A (en) | Traditional Chinese medicine composition for treating edema | |
| CN103735788A (en) | Traditional Chinese medicine composition for treating edema | |
| CN103007192B (en) | Chinese medicinal composition for treating thoracic obstruction | |
| CN103212041B (en) | Chinese medicinal composition treating coronary heart disease | |
| CN103705900A (en) | Traditional Chinese medicine composition for treating hypertension | |
| CN104888133A (en) | Traditional Chinese medicine composition for treatment of coronary heart disease | |
| CN104758439A (en) | Traditional Chinese medicine composition for treating thoracic obstruction | |
| CN102961561B (en) | Chinese medicinal composition for treating coronary heart disease | |
| CN102988632B (en) | Chinese medicinal composition for treating oedematous | |
| CN105770399A (en) | Traditional Chinese medicine composition for treating arrhythmia | |
| CN103316226B (en) | Traditional Chinese medicine composition for treating coronary heart disease | |
| CN104873685A (en) | Medicine for treating coronary heart disease | |
| CN104117018A (en) | Traditional Chinese medicine composition for treating coronary heart disease | |
| CN104623542A (en) | Traditional Chinese medicine composition for treating cervical spondylosis | |
| CN104758909A (en) | Traditional Chinese medicine composition for treating coronary heart disease | |
| CN105079768A (en) | Traditional Chinese medicine composition for treating coronary heart disease caused by syndrome of phlegm obstruction | |
| CN102961696A (en) | Chinese medicinal composition for treating diabetic nephropathy edema | |
| CN108498622A (en) | A kind of Chinese medicine composition for treating coronary heart disease | |
| CN106491946A (en) | One kind treats anginal Chinese medicine formula |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20150708 |